21 / 23
Auto-immuun hepatitis
Literatuurlijst
1.
Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ; Prevalence of sclerosing cholangitis in adults with autoimmune
hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 2008;47:949-957.
2.
Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, et al. Overlap syndromes: the International
Autoimmune Hepatitis Group(IAIHG) position statement on a controversial issue. J Hepatol 2011;54: 374–385.
3.
De Boer YS, Van Gerven NMF, Zwiers A, Verwer B, Van Hoek B, Van Erpecum KJ. The Dutch Autoimmune Hepatitis Study Group, The
LifeLines Cohort study, The Study of Health in Pomerania (SHIP). Genome-Wide Association Study Identifies Variants Associated
With Autoimmune Hepatitis Type 1. Gastroenterology. 2014, Aug;147(2):443-52.
4.
De Boer YS, van Nieuwkerk CMJ, Witte BI, Mulder CJJ, Bouma G, Bloemena E, Assesment of the hisotpathological key features in
autoimmune hepatitis; Histopathology 2015, 66, 351-362.
5.
Dermot Gleeson,1 Michael A Heneghan. British Society of Gastroenterology (BSG) guidelines for management of autoimmune
hepatitis. Gut, 2011.
6.
EASL Clinical Practice Guidelines: Autoimmune hepatitis. European Association for the Study of the Liver; Journal of Hepatology
2015 vol. 63 / 971–1004; Ansgar W. Lohse. Panel members: Olivier Chazouillères, George Dalekos, Joost Drenth, Michael Heneghan,
Harald Hofer, Frank Lammert, Marco Lenzi.
7.
Heurgue A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, et al. Overlap syndrome of primary biliary cirrhosis and
autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 2007;31:17–25.
8.
Kroep JR, Bolk JH, Weverling-Rijnsburger AWE, van Hoek B. Drie vrouwen met auto-immune hepatitis: het klinisch belang van
tijdige diagnose en van remissie. NTVG Ned Tijdschr Geneeskd 2005 29 oktober;149(44)klinische lessen.
9.
Nederlandse Leverpatienten Vereniging. Onderzoek onder mensen met ziektebeelden AIH, PBC of PSC. Mei 2009.
10. Nieuwsblad van de Nederlandse Vereniging voor Hepatologie; september 2015, jaargang 39, nr 3.
11. NLVisie; uitgave van de Nederlandse Leverpatienten Vereniging, juni 2013; auto-immuun aandoeningen.
12. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM; Diagnosis and Management of Autoimmune
Hepatitis. AASLD Practice Guidelines.
www.aasld.org.
13. Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C,et al. Health-related quality of life, depression, and anxiety
in patients with autoimmune hepatitis. J Hepatol 2014;60:618–624.
14. Van Gerven, promotie-onderzoek. Autoimmune Hepatitis in the Netherlands Epidemiological and clinical aspects.
15. Van Gerven NMF, de Boer YS, Zwiers A, Verwer BJ, Drenth JPH, van Hoek B, HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the
presentation and outcome in autoimmune hepatitis type-1.Genes and Immunity 2015,1-6.
16. Van Gerven NM, Bakker SF, de Boer YS, Witte BI, Bontkes H, van Nieuwkerk CM; Seroprevalence of celiac desease in patients with
autoimmune heptitis;European journal of Gastroenterlogy &Hepatology 2014.
17. Van Gerven NM, Verwer BJ, Witte BI, van Erpecum KJ, van Buuren HR, Maijers I, Dutch Autoimmune hepatitis STUDY
group. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014
Oct;49(10):1245-54.
18. Van Gerven NMF, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ. Relapse is almost universal after withdrawal of
immunosuppressive medication in patiënts with autoimmune hepatitis in remission, EASL; Joutnal of hepatology 2013 vol 58/141-
147.
19. Verwer BJ, Bouma G, Bloemena E, Schreuder TCMA, Mulder CJJ, van Nieuwkerk KMJ. Diagnose en behandeling van auto-immune
hepatitis. Ned. Tijdschrift voor Geneesk. 2009;153:A247.
20. Xia S, Han M, Li X, Cheng L, Qiang Y, Wu S. Dietery fish oil exacerbates concanavalin A induced hepatitis through promoting
hepatocyte apoptosis and altering immune cell populations. J Toxcol Sci. 2014 Apr;39(2):179-90.
19